Pharma-Bio Serv Revenue 2012-2026 | PBSV
Pharma-Bio Serv revenue from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Pharma-Bio Serv Annual Revenue (Millions of US $) |
|
|---|---|
| 2025 | $9 |
| 2024 | $10 |
| 2023 | $17 |
| 2022 | $19 |
| 2021 | $20 |
| 2020 | $22 |
| 2019 | $20 |
| 2018 | $18 |
| 2017 | $13 |
| 2016 | $20 |
| 2015 | $23 |
| 2014 | $28 |
| 2013 | $33 |
| 2012 | $29 |
| 2011 | $20 |
|
Pharma-Bio Serv Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2026-07-31 | $2 |
| 2026-04-30 | $3 |
| 2026-01-31 | $2 |
| 2025-10-31 | $2 |
| 2025-07-31 | $2 |
| 2025-04-30 | $2 |
| 2025-01-31 | $2 |
| 2024-10-31 | $2 |
| 2024-07-31 | $2 |
| 2024-04-30 | $2 |
| 2024-01-31 | $2 |
| 2023-10-31 | $4 |
| 2023-07-31 | $5 |
| 2023-04-30 | $5 |
| 2023-01-31 | $4 |
| 2022-10-31 | $5 |
| 2022-07-31 | $5 |
| 2022-04-30 | $5 |
| 2022-01-31 | $5 |
| 2021-10-31 | $6 |
| 2021-07-31 | $5 |
| 2021-04-30 | $5 |
| 2021-01-31 | $4 |
| 2020-10-31 | $5 |
| 2020-07-31 | $6 |
| 2020-04-30 | $6 |
| 2020-01-31 | $5 |
| 2019-10-31 | $5 |
| 2019-07-31 | $5 |
| 2019-04-30 | $5 |
| 2019-01-31 | $5 |
| 2018-10-31 | $6 |
| 2018-07-31 | $5 |
| 2018-04-30 | $4 |
| 2018-01-31 | $4 |
| 2017-10-31 | $1 |
| 2017-07-31 | $4 |
| 2017-04-30 | $4 |
| 2017-01-31 | $4 |
| 2016-10-31 | $5 |
| 2016-07-31 | $5 |
| 2016-04-30 | $5 |
| 2016-01-31 | $5 |
| 2015-10-31 | $6 |
| 2015-07-31 | $6 |
| 2015-04-30 | $5 |
| 2015-01-31 | $6 |
| 2014-10-31 | $7 |
| 2014-07-31 | $7 |
| 2014-04-30 | $7 |
| 2014-01-31 | $7 |
| 2013-10-31 | $9 |
| 2013-07-31 | $8 |
| 2013-04-30 | $8 |
| 2013-01-31 | $8 |
| 2012-10-31 | $8 |
| 2012-07-31 | $8 |
| 2012-04-30 | $7 |
| 2012-01-31 | $6 |
| 2011-10-31 | $6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Business Services | Consulting Services | $0.009B | $0.009B |
| Pharma-Bio Serv, Inc. provides consulting solutions to the pharmaceutical, chemical, medical device and biotechnology industries. Its services include regulatory compliance, validation, technology transfer, engineering, project management, process support, web pages, portals development, digital art design, intranets, extranets, software development, microbiological testing services, chemical testing services and technical trainings/seminars. The company operates in the U.S, Ireland and Spain. Pharma-Bio Serv, Inc. is headquartered in Dorado, Puerto Rico. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Equifax (EFX) | United States | $19.244B | 19.88 |
| Bureau Veritas Registre De Classification (BVRDF) | France | $14.189B | 0.00 |
| Gartner (IT) | United States | $12.097B | 13.31 |
| Booz Allen Hamilton Holding (BAH) | United States | $9.432B | 11.45 |
| Stantec (STN) | Canada | $7.914B | 17.01 |
| FTI Consulting (FCN) | United States | $4.007B | 17.19 |
| Exponent (EXPO) | United States | $3.234B | 30.50 |
| CBIZ (CBZ) | United States | $2.963B | 14.68 |
| Huron Consulting Group (HURN) | United States | $2.451B | 18.21 |
| Charles River Associates (CRAI) | United States | $1.032B | 19.88 |
| Hackett (HCKT) | United States | $0.273B | 10.88 |
| Information Services (III) | United States | $0.255B | 20.27 |
| Franklin Covey (FC) | United States | $0.201B | 24.74 |
| Accos (ACCL) | Hong Kong, SAR China | $0.040B | 0.00 |
| ATIF Holdings (ZBAI) | China | $0.011B | 0.00 |
| ATIF Holdings (AUC) | China | $0.009B | 0.00 |